Assignee
HUIGENE THERAPEUTICS CO LTD
CN·1 granted patent·6 pending applications·7 citations·filing 2020–2022
Top patents by PatentIndex Score
7 records- 0185US11225659B2Type VI-E and type VI-F CRISPR-Cas system and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2020·Granted Jan 18, 2022·7 cites·30 claims
- 0258US2023058054A1Crispr/cas system and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0357US2022389398A1Engineered crispr/cas13 system and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0447US2024209396A1Small cas proteins and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 0546US2023086489A1Novel design of guide rna and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0644US2023075045A1Engineered crispr/cas13 system and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0734US2023212605A1Adeno-associated virus vector and use thereofHUIGENE THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HUIGENE THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →